Your session is about to expire
← Back to Search
Pioglitazone for Alcoholism
Study Summary
This trial will examine if pioglitazone can help reduce stress-induced relapse risk and help with symptoms of drinking, stress/anxiety, and alcohol craving.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 4 trial • 20 Patients • NCT01612858Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you inform me of any additional research involving Pioglitazone?
"Currently, 31 clinical trials focusing on Pioglitazone are currently active and 4 of these studies have proceeded to Phase 3. Although Lausanne in Vaud is the primary location for such research, a total of 69 medical centres are running similar investigations."
What is the aggregate figure of participants involved in this clinical experiment?
"Affirmative. According to the information hosted on clinicaltrials.gov, this medical study is presently seeking participants. The trial was initially shared on May 12th 2022 and last updated August 29th 2022. 60 individuals are needed from one location."
Does this research project still have openings for participants?
"Affirmative. The clinical trial's presence on clinicaltrials.gov verifies that recruiting efforts are ongoing, beginning with its initial post date of May 12th 2022 and most recently updated on August 29th 2022. An estimated 60 individuals will be invited to join this study across one medical centre."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger